TWM
BIIB icon

Titus Wealth Management’s Biogen BIIB Stock Holding History

Titus Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$233K – 107
2019
Q3 		$233K Sell
1,000
-100
-9% -$23.3K 0.21% 87
2019
Q2 		$257K Hold
1,100
– – 0.25% 72
2019
Q1 		$260K Buy
+1,100
New +$346K 0.23% 83

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Titus Wealth Management's BIIB Position: Q4 2019 in Review

Titus Wealth Management sold out of Biogen (BIIB) in Q4 2019, closing a stake of 1,000 shares — an estimated $233K sold.

Titus Wealth Management first reported a position in BIIB in Q1 2019 and held it in 3 quarters. The position peaked at $260K in Q1 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Titus Wealth Management reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Titus Wealth Management sold 1,000 Biogen shares in Q4 2019, an estimated $233K.
  • Titus Wealth Management first reported a position in Biogen in Q1 2019 and held it in 3 quarters.
  • Titus Wealth Management's Biogen position peaked at $260K in Q1 2019.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Titus Wealth Management's 13F filing for Q4 2019, filed 18 Feb 2020.